Polymorphisms of genes for brain-derived neurotrophic factor, methylenetetrahydrofolate reductase, tyrosine hydroxylase, and endothelial nitric oxide synthase in depression and metabolic syndrome

Folia Biologica

Volumn 56, Issue 1, 2010, Pages 19-26

  Zeman, Miroslav ^a   Jachymova M ^b   Jirak R ^a   Vecka, M ^a   Tvrzicka E ^a   Stankova B ^a   Zak A ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

BDNF; Depression; Gene polymorphism; Metabolic syndrome

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BRAIN DERIVED NEUROTROPHIC FACTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; METHIONINE; TYROSINE 3 MONOOXYGENASE; VALINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MICROSATELLITE DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PROTEIN FUNCTION; AGED; CARDIOVASCULAR DISEASE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PILOT STUDY; RISK FACTOR;

ADULT; AGED; BRAIN-DERIVED NEUROTROPHIC FACTOR; CARDIOVASCULAR DISEASES; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METABOLIC SYNDROME X; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MICROSATELLITE REPEATS; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; PILOT PROJECTS; POLYMORPHISM, GENETIC; RISK FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 77949286063     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Alberti, K. G., Zimmet, P., Shaw, J. (2006) Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 23, 469-480.
2. Altar, C. A. (1999) Neurotrophins and depression. Trends Pharmacol. Sci. 20, 59-61.
3. American Psychiatric Association (1994) Diagnostic and Statistical Manual for Mental Disorders - Fourth Edition, American Psychiatric Press, Washington, DC.
4. Arinami, T., Yamada, N., Yamakawa-Kobayashi, K., Hamaguchi, H., Toru, M. (1997) Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am. J. Med. Genet. 74, 526-528.
5. Beneš, P., Kaňková, K., Mužík, J., Groch, L., Benedík, J., Elbl, L., Izakovičová-Hollá, L., Vašků, A., Znojil, V., Vácha, J. (2001) Methylenetetrahydrofolate reductase polymorphism, type II diabetes mellitus, coronary artery disease, and essential hypertension in the Czech population. Mol. Genet. Metab. 73, 188-195.
6. Bottiglieri, T., Laundy, M., Crellin, R., Toone, B. K., Carney, M. W., Reynolds, E. H. (2000) Homocysteine, folate, methylation, and monoamine metabolism in depression. J. Neurol. Neurosurg. Psychiatry 69, 228-232.
7. Castro, R., Rivera, I., Ravasco, P., Jakobs, C., Blom, H. J., Camilo, M. E., De Almeida, I. T. (2003) 5,10-Methylenetetrahydrofolate reductase 677C→T and 1298A→C mutations are genetic determinants of elevated homocysteine. Q. J. Med. 96, 297-303.
8. Chaldakov, G. N., Fiore, M., Stankulov, D. V., Hristova, M., Antonelli, A., Manni, L., Ghenev, P. I., Angelucci, F., Aloe, L. (2001) NGF, BDNF, leptin, and mast cells in human coronary atherosclerosis and metabolic syndrome. Arch. Physiol. Biochem. 109, 357-360.
9. Chen, Z. Y., Patel, P. D., Sant, G., Meng, C. X., Teng, K. K., Hempstead, B. L., Lee, F. S. (2004) Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wildtype BDNF in neurosecretory cells and cortical neurons. J. Neurosci. 24, 4401-4411.
10. Chen, Z. Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C. J., Herrera, D. G., Toth, M., Yang, C., McEwen, B. S., Hempstead, B. L., Lee, F. S. (2006) Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314, 140-143.
11. Choi, M. J., Kang, R. H., Lim, S. W., Oh, K. S., Lee, M. S. (2006) Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res. 1118, 176-182.
12. Chrapko, W. E., Juracz, P., Radomski, M. W., Lara, N., Archer, S., Le Melledo, J. M. (2004) Decreased plasma nitric oxide metabolites and platelet nitric oxide synthase activity in patients with major depression. Biol. Psychiatry 56, 129-134.
13. Czech Health Statistics Yearbook 2006, ÚZIS ČR, Prague, Czech Republic (2007).
14. Duman, R. S. (2004) Depression: a case of neuronal life and death? Biol. Psychiatry 56, 140-145.
15. Dwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., Pandey, G. N. (2003) Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch. Gen. Psychiatry 60, 804-815.
16. Ellingrod, V. L., Miller del, D., Taylor, S. F., Moline, J., Holman, T., Kerr, J. (2008) Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants. Schizophr. Res. 98, 47-54.
17. Folstein, M., Liu, T., Peter, I., Buell, J., Arsenault, L., Scott, T., Qiu, W. W. (2007) The homocysteine hypothesis of depression. Am. J. Psychiatry 164, 861-867.
18. Furlong, R. A., Rubinsztein, J. S., Luk, H., Walsh, C., Coleman, T. A., Muir, W. J., Paykel, E. S., Blackwood, D. H. R., Rubinsztein, D. C. (1999) Analysis and metaanalysis of two polymorphisms within the tyrosine hydroxylase gene in bipolar and unipolar affective disorders. Am. J. Med. Genet. 88, 88-94.
19. Galluccio, E., Piatti, P., Citterio, L., Lucotti, P. C. G., Setola, E., Cassina, L., Oldani, M., Zavaroni, I., Bosi, E., Colombo, A., Alfieri, O., Casari, G., Reaven, G. M., Monti, L. D. (2008) Hyperinsulinemia and impaired leptin-adiponectin ratio associate with endothelial nitric oxide synthase polymorphisms in subjects with in-stent restenosis. Am. J. Physiol. Endocrinol. Metab. 294, E978-E986.
20. Grundy, S. M. (2008) Metabolic syndrome pandemic. Arterioscler. Thromb. Vasc. Biol. 28, 629-636.
21. Herrmann, W. (2006) Significance of hyperhomocysteinemia. Clin. Lab. 52, 367-374.
22. Hong, C. J., Huo, S. J., Yen, F. C., Tung, C. L., Pan, G. M., Tsai, S. J. (2003) Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 48, 186-189.
23. Iga, J., Ueno, S., Yamauchi, K., Numata, S., Tayoshi-Shibuya, S., Kinouchi, S., Nakataki, M., Song, H., Hokoishi, K., Tanabe, H., Sano, A., Ohmori, T. (2007) The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B, 1003-1006.
24. Jáchymová, M., Horký, K., Bultas, J., Kožich, V., Jindra, A., Peleška, J., Martásek, P. (2001) Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem. Biophys. Res. Comm. 284, 426-430.
25. Jindra, A., Jáchymová, M., Horký, K., Peleška, J., Umnerová, V., Bultas, J., Šavlí ková, J. (2000) Association analysis of two tyrosine hydroxylase gene polymorphisms in normotensive offspring from hypertensive families. Blood Press. 9, 250-254.
26. Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., Aubry, J. M. (2002). Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 109, 143-148.
27. Kaufman, J., Yang, B. Z., Douglas-Palumberi, H., Grasso, D., Lipschitz, D., Houshyar, S., Krystala, J. H., Gelernter, J. (2006) Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol. Psychiatry 59, 673-680.
28. Kempermann, G., Kronenberg, G. (2003) Depressed new neurons - adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biol. Psychiatry 54, 499-503.
29. Kempisty, B., Bober, A., Łuczak, M., Czerski, P., Szczepankiewicz, A., Hauser, J., Jagodziński, P. P. (2007) Distribution of 1298 A > C polymorphism of methylenetetrahydrofolate reductase gene in patients with bipolar disorder and schizophrenia. Eur. Psychiatry 22, 39-43.
30. Klintschar, M., Immel, U. D., Stiller, D., Kleiber, M. (2005) TH01, a tetrameric short tandem repeat locus in the tyrosine hydroxylase gene: association with myocardial hypertrophy and death from myocardial infarction? Dis. Markers 21, 9-13.
31. Krabbe, K. S., Nielsen, A. R., Krogh-Madsen, R., Plomgaard, P., Rasmussen, P., Erikstrup, C., Fischer, C., Lindegaard, B., Petersen, A., Taudorf, S., Secher, N., Pilegaard, H., Bruunsgaard, H., Pedersen, B. (2007) Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 50, 431-438.
32. Kunugi, H., Nanko, S., Hirasawa, H., Kato, N., Nabika, T., Kobayashi, S. (2003) Brain-derived neurotrophic factor gene and schizophrenia: polymorphism screening and association analysis. Schizophr. Res. 62, 281-283.
33. Kynugi, H., Iijima, Y., Tatsumi, M., Yoshida, M., Hashimoto, R., Kato, T., Sakamoto, K., Fukumada, F., Inada, T., Suzuji, T., Iwata, N., Ozaki, N., Yamada, K., Yoshikawa, T. (2004) No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study. Biol. Psychiatry 56, 376-378.
34. Le Mellédo, J.-M., Mahil, N., Baker, G. B. (2004) Nitric oxide: A key player in the relation between cardiovascular disease and major depressive disorder? J. Psychiatry Neurosci. 29, 414-416.
35. Leboyer, M., Malafosse, A., Boularand, S., Campion, D., Gheysen, F., Samolyk, D., Henriksson, B., Denise, E., des Lauriers, A., Lepine, J. P. (1990) Tyrosine hydroxylase polymorphisms associated with manic-depressive illness. Lancet 335, 1219.
36. Lesch, K. P. (2004) Gene-environment interaction and the genetics of depression. J. Psychiatry Neurosci. 29, 174-182.
37. Levin, B. E. (2007) Neurotrophism and energy homeostasis - perfect together. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R988-R991.
38. Levinson, D. F. (2006) The genetics of depression: a review. Biol. Psychiatry 60, 84-92.
39. Lewis, S. J., Lawlor, D. A., Davey Smith, G., Araya, R., Timpson, N., Day, I. N. M., Ebrahim, S. (2006) The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis. Mol. Psychiatry 11, 352-360.
40. López-León, S., Janssens, A. C. J. W., González- Zuloeta Ladd, A. M., Del-Favero, J., Claes, S. J., Oostraand, B. A., van Duijn, C. M. (2008) Meta-analyses of genetic studies on major depressive disorder. Mol. Psychiatry 13, 772-785.
41. López-Miranda, J., Pérez-Martínez, P., Marin, C., Fuentes, F., Delgado, J., Pérez-Jiménez, F. (2007) Dietary fat, genes and insulin sensitivity. J. Mol. Med. 85, 213-226.
42. Maisonpierre, P. C., Le Beau, M. M., Espinosa, R., Ip, N. Y., Belluscio, L., de la Monte, S. M., Squinto, S., Furth, M. E., Yancopoulos, G. D. (1991) Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 10, 558-568.
43. Mc Ewen, B. S. (2005) Glucocorticoids, depression and mood disorders: structural remodeling in the brain. Metabolism 54 (Suppl 1), 20-23.
44. McGuffin, P., Katz, R., Watkins, S., Rutherford, J. (1996) A hospital-based twin register of the heritability of DSM-IV unipolar depression. Arch. Gen. Psychiatry 53, 129-136.
45. Miller, S. A., Dykes, D. D., Polesky, H. F. (1988) A simple salting out extraction DNA from human nucleated cells. Nucleic Acids Res. 16, 1215.
46. Montag, C., Basten, U., Stelzel, C., Fiebach, C. J., Reuter, M. (2008) The BDNF Val66Met polymorphism and smoking. Neurosci. Lett. 442, 30-33.
47. Musselman, D. L., Evans, D. L., Nemeroff, C. B. (1998) The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch. Gen. Psychiatry 55, 580-592.
48. Musselman, D. L., Betan, E., Larsen, H., Phillips, L. S. (2003) Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol. Psychiatry 54, 317-329.
49. Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch A. J., Gold S. J., Monteggia L. M. (2002) Neurobiology of depression. Neuron 34, 13-25.
50. Okamura, F., Tashiro, A., Utumi, A., Imai, T., Suchi, T., Tamura, D., Sato, Y., Suzuki, S., Hongo, M. (2000) Insulin resistance in patients with depression and its changes during the clinical course of depression: Minimal model analysis. Metabolism 49, 1255-1260.
51. Pacher, P., Beckman, J. S., Liaudet, L. (2007) Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315-424.
52. Peakall, R., Smouse P. E. (2005) GenAlEx V6: Genetic analysis in Excel. Population genetic software for teaching and research, Australian National University, Canberra. Available via http://www.anu.edu.au/ BoZo/GenAlEx.
53. Pröschel, M., Saunders, A., Roses, A. D., Müller, C. R. (1992) Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF). Hum. Mol. Genet. 1, 353.
54. Rao, F., Zhang, L., Wessel, J., Zhang, K., Wen, G., Kennedy, B. P., Rana, B. K., Das, M., Rodriguez-Flores, J. L., Smith, D. W., Cadman, P. E., Salem, R. M., Mahata, S. K., Schork, N. J., Taupenot, L., Ziegler, M. G., O'Connor, D. T. (2007) Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo. Circulation 116, 993-1006.
55. Reaven, G. M. (2002) Metabolic syndrome. Pathophysiology and implications for management of cardiovascular disease. Circulation 106, 286-288.
56. Ribeiro, L., Busnello, J. V, Cantor, R. M., Whelan, F., Whittaker, P., Deloukas, P., Wong, M. L., Licinio, J. (2007) The brain-derived neurotrophic factor rs6265 (Va166Met) polymorphism and depression in Mexican-Americans. NeuroReport 18, 1291-1293.
57. Sen, S., Nesse, R. M., Stoltenberg, S. F., Li, S., Gleiberman, L., Chakravarti, A., Weder, A. B., Burmeister, M. (2003) A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 28, 397-401.
58. Sen, S., Duman, R, Sanacora, G. (2008) Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta analyses and implications. Biol. Psychiatry 64, 527-532.
59. Serretti, A., Macciardi, F., Verga, M., Cusin, C., Pedrini, S., Smeraldi, E. (1998) Tyrosine hydroxylase gene associated with depressive symptomatology in mood disorder. Am. J. Med. Genet. 8, 127-130.
60. Shimizu, E., Hashimoto, K., Iyo, M. (2004) Ethnic difference of the BDNF 196G/A (va166met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am. J. Med. Genet. B Neuropsychiatr. Genet. 126, 122-123.
61. Sklar, P., Gabriel, S. B., McInnis, M. G., Bennett, P., Lim, Y. M., Tsan G., Schaffner, S., Kirov, G., Jones, I., Owen, M., Craddock, N., DePaulo J. R., Lander, E. S.(2002) Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus: Brain-derived neurotrophic factor. Mol. Psychiatry 7, 579-593.
62. Surtees, P. G., Wainwright, N. W., Willis-Owen, S. A., Sandhu, M. S., Luben, R., Day, N. E., Flint, J. (2007) No association between the BDNF Va166Met polymorphism and mood status in a non-clinical community sample of 7389 older adults. J. Psychiatr. Res. 41, 404-409.
63. Terruzzi, L, Senesi, P., Fermo, I., Lattuada, G., Luzi, L. (2007) Are genetic variants of the methyl group metabolism enzymes risk factors predisposing to obesity? J. Endocrinol. Invest. 30, 747-753.
64. Veselá, K., Pavlíková, M., Janoší ková, B., Anděl, M., Zvárová, J., Hyánek, J., Kožich, V. (2005) Genetic determinants of folate status in Central Bohemia. Physiol. Res. 54, 295-303.
65. Wulsin, L. R, Vaillant, G. E., Wells, V. E. (1999). A systematic review of the mortality of depression. Psychosom. Med. 61, 6-17.
66. Zǎk, A., Zeman, M. (2004) Consequences of moderate hyperhomocysteinaemia in internal medicine. Cas. Lek. Cesk. 143, 367-374. (In Czech)
67. Zhang, L., Rao, F., Wessel, J., Kennedy, B. P., Rana, B. K., Taupenot, L., Lillie, E. O., Cockburn, M., Schork, N. J., Ziegler, M. G., O'Connor, D. T. (2004) Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins. Physiol. Genomics 19, 277-291.